プラチナバイオ株式会社
東広島市, JP · 2 known investors
Find your way into プラチナバイオ株式会社
575 people in our graph share verified history with the プラチナバイオ株式会社 team — schools, employers, funds. One of them is your warm intro.
Shinji Amahaunlockedknows Hidemasa Bono · together at The University of Tokyo (overlapped)
×2knows the team · via INSEAD
×3knows the team · via Keio University
×5knows the team · via Arthur D. Little
knows the team · via Tohoku University
PtBio develops genome editing technology and bio-DX tools for analyzing the genomes of industrially used organisms, positioning itself as a platform provider. Its applications include allergy-free eggs, CO2-converting microalgae for carbon recycling, advanced medical treatments, resource-recycling agriculture, aquatic resource supply, and bio-manufacturing.
Founders & leadership
KO
Keisuke OkuharainRepresentative Director & CEOKeisuke Okuhara holds a Master of Science degree and has worked across government agencies before founding PtBio, where he serves as Representative Director and CEO. The company develops genome editing technology and bio-diagnostic tools for industrial organisms, with applications spanning agriculture, pharmaceuticals, and biomanufacturing.
奥啓
奥原 啓輔代表取締役 (Representative Director)
TY
Takashi YamamotoDirector & CTO
AI
Atsuhiro IshiiinCOOAtsuhiro Ishii holds a master's degree in Electrical and Electronics Engineering from Keio University with specialization in laser drug delivery, and spent over four years as a consultant at Arthur D. Little before joining PtBio, where he progressed from Business Co-creation Director to COO overseeing business strategy and operations.
HB
Hidemasa BonoinCSO (Chief Scientific Officer)Hidemasa Bono holds a Ph.D. in Science from Kyoto University and has held research and faculty positions in genomics at institutions including the RIKEN Yokohama Research Center, Saitama Medical University, and Hiroshima University, where he is currently a professor and deputy director of the Genome Editing Innovation Center.
YK
Yumiko KusakabeinChief Strategy OfficerYumiko Kusakabe is Chief Strategy Officer at PtBio, which develops genome editing and bio-diagnostic tools for industrial organisms. She brings 19 years of international banking and emerging markets experience, along with expertise in structured finance, project finance, and open innovation strategy across genomics, biotech, and agritech sectors.
Investors · 2
Frequently asked questions
- What does プラチナバイオ株式会社 do?
- PtBio develops genome editing technology and bio-DX tools for analyzing the genomes of industrially used organisms, positioning itself as a platform provider. Its applications include allergy-free eggs, CO2-converting microalgae for carbon recycling, advanced medical treatments, resource-recycling agriculture, aquatic resource supply, and bio-manufacturing.
- Who founded プラチナバイオ株式会社?
- プラチナバイオ株式会社 was founded by Keisuke Okuhara.
- Who are プラチナバイオ株式会社's investors?
- プラチナバイオ株式会社's investors include Hiroshima Venture Capital Co. Ltd., Kobe University Capital.
- Where is プラチナバイオ株式会社 headquartered?
- プラチナバイオ株式会社 is headquartered in 東広島市, JP.